Clinical trial · no report yet · Phase not applicable
PARTIQoL
Proton Therapy vs. IMRT for Low or Intermediate Risk Prostate Cancer
- NCT01617161 ↗
- Active not recruiting
- Massachusetts General Hospital
- 67 commentary sources found
- Deep
We haven't built a report for this trial yet. This page shows the registry record and the public commentary we found that names the trial. A report reads that commentary and sets out what clinicians said about the trial, each point linked to its source. How reports are made.
Commentary we found
Podcasts, YouTube videos and X posts in our index that name this trial. A report screens them, searches for more and cites what clinicians said when it is built.
| Channel | Found | |
|---|---|---|
| X threads | 62 | |
| YouTube | 3 | |
| Podcasts | 2 |
The trial
ClinicalTrials.gov- Official title
- Prostate Advanced Radiation Technologies Investigating Quality of Life (PARTIQoL): A Phase III Randomized Clinical Trial of Proton Therapy vs IMRT for Low or Intermediate Risk Prostate Cancer
- Phase
- Phase not applicable
- Status
- Active not recruiting
- Conditions
- Prostate Cancer
- Interventions
- Proton Beam Therapy; Intensity Modulated Radiation Therapy
- Arms
- PBT · Active comparator
- IMRT · Active comparator
- Enrollment
- 454
- Primary outcomes
- Efficacy of PBT vs. IMRT
- Sponsor
- Massachusetts General Hospital with University of Pennsylvania, National Cancer Institute (NCI), Northwestern Medicine Chicago Proton Center, ProCure Proton Therapy Center, Washington University School of Medicine, University of Washington, Rutgers Cancer Institute of New Jersey, Mayo Clinic, University of Maryland, Baltimore, University Hospitals Cleveland Medical Center, University of Florida, Provision Center for Proton Therapy
- Start
- Jul 25, 2012
- Primary completion
- Dec 2025
- Results posted
- No
- Registry record
- NCT01617161 · updated Sep 11, 2026
Publications
linked from the registry- Liu Y, Patel SA, Jani AB, Gillespie TW, Patel PR, Godette KD, Hershatter BW, Shelton JW, McDonald MW. Overall Survival After Treatment of Localized Prostate Cancer With Proton Beam Therapy, External-Beam Photon Therapy, or Brachytherapy. Clin Genitourin Cancer. 2021 Jun;19(3):255-266.e7. doi: 10.1016/j.clgc.2020.08.009. Epub 2020 Aug 28. PubMed 32972877